Clinical Trial Update: Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older [Phase 2]

View source ↗

Summary

A Phase 2 trial update of a novel influenza A/H1N1 split-virion vaccine evaluated in healthy participants aged 3 years and older.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Infection

Drugs mentioned

• Influenza A/H1N1 split-virion vaccine

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Virus Diseases, Respiratory Tract Diseases | Phase 2 | Status: COMPLETED